Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 2/20 | 0.37 |
| ▸ | TSHR | P16473 | 2/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | SRC | P12931 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | GRM2 | Q14416 | 2/20 | 0.36 |
| ▸ | GRM3 | Q14832 | 2/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.35 |
| ▸ | THRB | P10828 | 1/20 | 0.35 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL242257 | 0.79 | CES2 (0.52) | CYP2D6TSHRMAPK1CYP3A4CYP1A2 | |
| SCHEMBL3761182 | 0.76 | ALDH1A1 (0.44) | CYP2D6TSHRMAPK1MEN1KMT2A | |
| SCHEMBL1173291 | 0.72 | CYP2D6 (0.48) | CYP2D6TSHRMAPK1MEN1KMT2A | |
| SCHEMBL9823813 | 0.72 | CYP2D6 (0.48) | CYP2D6TSHRMAPK1MEN1KMT2A | |
| SCHEMBL286907 | 0.72 | CYP2D6 (0.48) | CYP2D6TSHRMAPK1MEN1KMT2A | |
| SCHEMBL9181806 | 0.69 | CYP2D6 (0.50) | CYP2D6TSHRMAPK1MEN1KMT2A | |
| SCHEMBL664900 | 0.69 | SRC (0.56) | CYP2D6TSHRMAPK1CYP3A4HSD17B10 | |
| SCHEMBL5325296 | 0.69 | SRC (0.56) | CYP2D6TSHRMAPK1CYP3A4HSD17B10 | |
| SCHEMBL8698888 | 0.69 | CYP2D6 (0.44) | CYP2D6TSHRMAPK1MEN1KMT2A | |
| SCHEMBL14244778 | 0.68 | RECQL (0.60) | TSHRCYP3A4HSD17B10MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110003847-A1 | Prasugrel Salts with Improved Properties | HELM AG (DE) | 2011-01-06 | — | — | US | disclosed |
| EP-2257556-A1 | PRASUGREL SALTS WITH IMPROVED PROPERTIES | Helm AG (DE) | 2010-12-08 | — | — | EP | disclosed |
| WO-2009098142-A1 | PRASUGREL SALTS WITH IMPROVED PROPERTIES | HELM AG (DE) | 2009-08-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110003847-A1 | Prasugrel Salts with Improved Properties | P2RY6, PF4, PFKP | CYP2D6 49/4885TSHR 4161/4885MAPK1 1395/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.